Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction

This publication has 35 references indexed in Scilit:

• Delayed Reperfusion Alters Matrix Metalloproteinase Activity and Fibronectin mRNA Expression in the Infarct Zone of the Ligated Rat Heart
  Journal of Molecular and Cellular Cardiology, 1997
• Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine
  American Heart Journal, 1996
• Diagnostic Value of B-Type Natriuretic Peptide Concentrations in Patients With Acute Myocardial Infarction
  Published by Elsevier ,1996
• Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty
  American Heart Journal, 1995
• Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction
  Journal of the American College of Cardiology, 1995
• Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
  Published by Elsevier ,1993
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
  Journal of Clinical Investigation, 1991
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Scintigraphic evidence of the “No reflow” phenomenon in human beings after coronary thrombolysis
  Journal of the American College of Cardiology, 1985
• The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the Dog
  Journal of Clinical Investigation, 1974